Submitted on September 13, 2006
Accepted on December 7, 2006
Identifying Children at Risk for Polycystic Ovary Syndrome
Robert L Rosenfield MD*
The University of Chicago Pritzker School of Medicine, Department of Pediatrics, Section of Pediatric Endocrinology, The University of Chicago Comer Children's Hospital, 5841 S Maryland Ave, MC-5053, Chicago, IL 60637, Phone: 773-702-6432, Fax: 773-702=0443, E-mail: robros@peds.bsd.uchicago.edu
* To whom correspondence should be addressed. E-mail: robros{at}peds.bsd.uchicago.edu.
Context: Polycystic ovary syndrome (PCOS) appears to arise asa complex trait with contributions from both heritable and non-heritablefactors. Polygenic influences appear to account for about 70%of the variance in pathogenesis. In view of this evidence forcongenital contributions to the syndrome, childhood manifestationsmay be expected.
Objective: The objective has been to reviewthe evidence that risk factors for PCOS can be recognized inchildhood.
Design/Setting: Screening of the PCOS literaturefor articles pertaining to potential childhood and adolescentantecedents.
Results: Congenital virilizing disorders; above-averageor low birth-weight for gestational age; premature adrenarche,particularly exaggerated adrenarche; atypical sexual precocity;or intractable obesity with acanthosis nigricans, metabolicsyndrome, and pseudo-Cushing syndrome or pseudo-acromegaly inearly childhood have been identified as independent prepubertalrisk factors for the development of PCOS. During adolescence,PCOS may masquerade as physiologic adolescent anovulation. Asymptomaticadolescents with a polycystic ovary occasionally (8%) have subclinicalPCOS, but often (42%) have a subclinical PCOS-type of ovariandysfunction, the prognosis for which is unclear.
Conclusion:Identifying children at risk for PCOS offers the prospect ofeventually preventing some of the long-term complications associatedwith this syndrome once our understanding of the basis of thedisorder improves.
P. Utriainen, J. Jaaskelainen, A. Saarinen, E. Vanninen, O. Makitie, and R. Voutilainen Body Composition and Bone Mineral Density in Children with Premature Adrenarche and the Association of LRP5 Gene Polymorphisms with Bone Mineral Density
J. Clin. Endocrinol. Metab.,
November 1, 2009;
94(11):
4144 - 4151.
[Abstract][Full Text][PDF]
M. Maliqueo, T. Sir-Petermann, V. Perez, B. Echiburu, A. Ladron de Guevara, C. Galvez, N. Crisosto, and R. Azziz Adrenal Function during Childhood and Puberty in Daughters of Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab.,
September 1, 2009;
94(9):
3282 - 3288.
[Abstract][Full Text][PDF]
V. Padmanabhan Polycystic Ovary Syndrome -- "A Riddle Wrapped in a Mystery inside an Enigma"
J. Clin. Endocrinol. Metab.,
June 1, 2009;
94(6):
1883 - 1885.
[Full Text][PDF]
T. Sir-Petermann, E. Codner, V. Perez, B. Echiburu, M. Maliqueo, A. Ladron de Guevara, J. Preisler, N. Crisosto, F. Sanchez, F. Cassorla, et al. Metabolic and Reproductive Features before and during Puberty in Daughters of Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab.,
June 1, 2009;
94(6):
1923 - 1930.
[Abstract][Full Text][PDF]
G. A. Dissen, C. Garcia-Rudaz, A. Paredes, C. Mayer, A. Mayerhofer, and S. R. Ojeda Excessive Ovarian Production of Nerve Growth Factor Facilitates Development of Cystic Ovarian Morphology in Mice and Is a Feature of Polycystic Ovarian Syndrome in Humans
Endocrinology,
June 1, 2009;
150(6):
2906 - 2914.
[Abstract][Full Text][PDF]
P. Utriainen, R. Voutilainen, and J. Jaaskelainen Continuum of phenotypes and sympathoadrenal function in premature adrenarche
Eur. J. Endocrinol.,
April 1, 2009;
160(4):
657 - 665.
[Abstract][Full Text][PDF]
B. Bordini, E. Littlejohn, and R. L. Rosenfield Blunted Sleep-Related Luteinizing Hormone Rise in Healthy Premenarcheal Pubertal Girls with Elevated Body Mass Index
J. Clin. Endocrinol. Metab.,
April 1, 2009;
94(4):
1168 - 1175.
[Abstract][Full Text][PDF]
J.-C. Carel, E. A. Eugster, A. Rogol, L. Ghizzoni, M. R. Palmert, and on behalf of the members of the ESPE-LWPES GnRH An Consensus Statement on the Use of Gonadotropin-Releasing Hormone Analogs in Children
Pediatrics,
April 1, 2009;
123(4):
e752 - e762.
[Abstract][Full Text][PDF]
F. Chiarelli and M. L. Marcovecchio Insulin resistance and obesity in childhood
Eur. J. Endocrinol.,
December 1, 2008;
159(suppl_1):
S67 - S74.
[Abstract][Full Text][PDF]
D. H Abbott, D. K Barnett, J. E Levine, V. Padmanabhan, D. A Dumesic, S. Jacoris, and A. F Tarantal Endocrine Antecedents of Polycystic Ovary Syndrome in Fetal and Infant Prenatally Androgenized Female Rhesus Monkeys
Biol Reprod,
July 1, 2008;
79(1):
154 - 163.
[Abstract][Full Text][PDF]
S. C. Kent, C. L. Gnatuk, A. R. Kunselman, L. M. Demers, P. A. Lee, and R. S. Legro Hyperandrogenism and Hyperinsulinism in Children of Women with Polycystic Ovary Syndrome: A Controlled Study
J. Clin. Endocrinol. Metab.,
May 1, 2008;
93(5):
1662 - 1669.
[Abstract][Full Text][PDF]
S. Lappalainen, P. Utriainen, T. Kuulasmaa, R. Voutilainen, and J. Jaaskelainen Androgen Receptor Gene CAG Repeat Polymorphism and X-Chromosome Inactivation in Children with Premature Adrenarche
J. Clin. Endocrinol. Metab.,
April 1, 2008;
93(4):
1304 - 1309.
[Abstract][Full Text][PDF]
A. Veiga-Lopez, W. Ye, D.J. Phillips, C. Herkimer, P.G. Knight, and V. Padmanabhan Developmental Programming: Deficits in Reproductive Hormone Dynamics and Ovulatory Outcomes in Prenatal, Testosterone-Treated Sheep
Biol Reprod,
April 1, 2008;
78(4):
636 - 647.
[Abstract][Full Text][PDF]
E. Codner, G. Iniguez, C. Villarroel, P. Lopez, N. Soto, T. Sir-Petermann, F. Cassorla, and R. A. Rey Hormonal Profile in Women with Polycystic Ovarian Syndrome with or without Type 1 Diabetes Mellitus
J. Clin. Endocrinol. Metab.,
December 1, 2007;
92(12):
4742 - 4746.
[Abstract][Full Text][PDF]